Joshua Sonkiss, MD

Identifying and Treating Substance Use in Correctional Settings

April 1, 2025

Joshua Sonkiss, MD. President of Sonkiss Medical Consulting, LLC, Tucson, AZ.

Dr. Sonkiss has no financial relationships with companies related to this material.

Substance use in correctional settings is a hidden crisis that significantly impacts the health and safety of both patients and staff.

CLINICAL UPDATE

Using DBT Skills in Everyday Clinical Practice: An In-Depth Overview for Therapists

July 10, 2023

Joshua Sonkiss, MD

Joshua Sonkiss, MD. Board-certified in adult, adolescent, and forensic psychiatry as well as addiction medicine.

Dr. Sonkiss has no financial relationships with companies related to this material.

DBT: a comprehensive treatment approach that combines mindfulness, cognitive-behavioral techniques, acceptance-based therapy, and case management to help individuals develop skills for emotional regulation and behavior change.

FDA Approves Lucemyra—But Is It Better Than Clonidine?

November 8, 2018

Joshua Sonkiss, MD

Joshua Sonkiss, MD Dr. Sonkiss has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

On May 16, 2018, the FDA announced its approval of Lucemyra (lofexidine) as a drug to help patients withdraw from opioids. Like clonidine, lofexidine is an alpha-2 agonist, but it is touted as causing less orthostatic hypotension and therefore being somewhat safer to use.

A Kratom Update

January 1, 2017

Joshua Sonkiss, MD

Joshua Sonkiss, MD Editor-in-chief, The Carlat Addiction Treatment Report

If you have not yet heard of kratom (usually pronounced kray-tom or krah-tom), consider this an introduction. Kratom preparations are gaining popularity among substance users because of the plant’s opioid-like and stimulant properties.

How to Read a Research Article

July 1, 2014

Joshua Sonkiss, MD

Joshua Sonkiss, MD Medical director, Behavioral Health Unit, Fairbanks Memorial Hospital, Fairbanks, AK Dr. Sonkiss has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

As a physician, you’re expected to practice evidence-based medicine. But how can anyone keep up with the latest research?